Security Snapshot

Hims & Hers Health, Inc. - Class A Common Stock, $0.0001 par value per share (HIMS) Institutional Ownership

CUSIP: 433000106

13F Institutional Holders and Ownership History from Q1 2020 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

342

Shares (Excl. Options)

92.76MFull value: 92,760,999 · shares · 30 Sep 2026

Price

$29.79

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-2,814,657
Value change
-$126,567,944
Number of holders
342
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
223,790,875
SEC-reported price per share
$29.67
Insider filing price
$29.67
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • HIMS - Hims & Hers Health, Inc. - Class A Common Stock, $0.0001 par value per share is tracked under CUSIP 433000106.
  • 342 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 511 to 342 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $5.39BFull value: $5,391,282,570 · USD · 30 Jun 2026
    to
    $2.76BFull value: $2,758,735,408 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 342 institutions filings for Q3 2026.

Open SEC evidence

Security key

433000106

13F reference period

Q3 2026

13F holders

342

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
HIMS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% +10% $918,623,878 +$119,582,065 26,496,218 +15% BlackRock, Inc. 30 Jun 2026
Dudum Andrew 9.4% -9% $650,489,758 -$34,837,679 22,610,002 -5.1% Andrew Dudum 27 Aug 2026
Capital World Investors 6.5% -23% $461,197,766 -$136,411,758 14,322,912 -23% Capital World Investors 31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC 5% -0.8% $333,353,526 +$38,965 11,190,115 +0.01% Vanguard Capital Management 30 Sep 2026
SUSQUEHANNA SECURITIES, LLC 4.8% -24% $319,143,691 -$111,722,464 10,741,962 -26% G1 Execution Services, LLC 30 Sep 2026
JPMORGAN CHASE & CO 1.7% -80% $61,332,282 -$219,856,510 3,881,790 -78% JPMORGAN CHASE & CO. 27 Feb 2026
As of 30 Sep 2026, 342 institutional investors reported holding
92.76MFull value: 92,760,999 · shares · 30 Sep 2026
shares of Hims & Hers Health, Inc. - Class A Common Stock, $0.0001 par value per share (HIMS). This represents 41% of the company’s total
223.79MFull value: 223,790,875 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
29%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD PORTFOLIO MANAGEMENT LLC 4.7% 10,409,131 0.01% $310,088,012
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 9,526,404 0.01% $283,791,575
STATE STREET CORP 3.7% 8,239,957 0.01% $245,468,319
Divisadero Street Capital Management, LP 3.3% 7,344,028 3.9% $218,778,594
GEODE CAPITAL MANAGEMENT, LLC 2.5% 5,630,567 0.01% $167,766,031
TWO SIGMA INVESTMENTS, LP 2% 4,369,652 0.09% $130,171,933
GOLDMAN SACHS GROUP INC 1.7% 3,880,161 0.01% $115,590,004
VANGUARD FIDUCIARY TRUST CO 0.68% 1,518,964 0.01% $45,249,938
BANK OF AMERICA CORP /DE/ 0.57% 1,270,640 0% $37,852,367
Quadrature Capital Ltd 0.54% 1,209,178 0.22% $36,021,414
STATE OF MICHIGAN RETIREMENT SYSTEM 0.54% 1,207,782 0.16% $35,979,826
Corient Private Wealth LP 0.53% 1,188,290 0.03% $35,399,141
SCHRODER INVESTMENT MANAGEMENT GROUP 0.49% 1,088,864 0.02% $31,250,397
Bienville Capital Management, LLC 0.44% 974,672 3.4% $29,035,479
DIMENSIONAL FUND ADVISORS LP 0.41% 914,688 0% $27,248,555
Foresite Capital Management V, LLC 0.39% 883,751 9.1% $26,326,942
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.37% 820,085 0.02% $24,430,332
Casdin Capital, LLC 0.36% 800,000 1% $23,832,000
BAILLIE GIFFORD & CO 0.36% 794,827 0.02% $23,677,897
KINGDON CAPITAL MANAGEMENT, L.L.C. 0.28% 624,278 2.8% $18,597,242
Capital World Investors 0.27% 606,726 0% $18,074,364
NATIONAL BANK OF CANADA /FI/ 0.23% 517,246 0.01% $15,409,367
Marex Group Ltd 0.21% 466,327 0.13% $13,891,881
WELLINGTON MANAGEMENT GROUP LLP 0.2% 447,512 0% $13,331,382
Clear Street Group Inc. 0.19% 430,957 0.05% $12,838,209

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
26
Headline period
Q3 2026
Rows shown
1-25 of 26
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 92,760,999 $2,758,735,408 -$126,567,944 $29.79 342
2026 Q2 155,901,681 $5,391,282,570 +$438,677,489 $34.67 511
2026 Q1 148,873,273 $3,079,386,491 -$910,513,563 $20.76 434
2025 Q4 183,339,602 $5,958,165,218 -$669,117,583 $32.47 486
2025 Q3 199,883,212 $11,335,508,253 +$1,437,053,454 $56.72 508
2025 Q2 175,272,401 $8,737,551,983 +$961,576,555 $49.85 501
2025 Q1 156,499,038 $4,623,681,560 -$176,903,936 $29.55 418
2024 Q4 164,535,250 $3,980,113,570 +$662,356,870 $24.18 385
2024 Q3 137,388,700 $2,532,982,313 +$13,483,116 $18.42 302
2024 Q2 135,555,935 $2,737,194,047 +$237,895,932 $20.19 291
2024 Q1 127,014,197 $1,964,665,169 +$120,987,021 $15.47 236
2023 Q4 124,812,595 $1,110,858,696 -$20,511,047 $8.90 194
2023 Q3 119,054,225 $748,816,065 -$112,963,918 $6.29 189
2023 Q2 132,438,140 $1,244,975,489 +$139,460,952 $9.40 185
2023 Q1 119,222,566 $1,182,050,601 +$138,780,557 $9.92 185
2022 Q4 105,528,105 $676,436,778 +$198,928,135 $6.41 151
2022 Q3 94,761,647 $528,756,939 +$31,959,823 $5.58 145
2022 Q2 89,005,896 $403,186,006 +$45,235,978 $4.53 132
2022 Q1 78,422,127 $417,949,018 -$13,253,687 $5.33 127
2021 Q4 70,024,982 $458,628,840 +$14,988,392 $6.55 137
2021 Q3 42,323,200 $319,091,740 -$102,457,566 $7.54 107
2021 Q2 54,478,149 $592,933,897 +$19,733,325 $10.89 84
2021 Q1 52,489,763 $692,968,615 +$689,881,615 $13.23 80
2020 Q4 186,615 $2,725,000 +$2,725,000 $14.60 1
2020 Q3 0 $0 -$53,000 $29.67 0
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .